ISRG — Intuitive Surgical, Inc. stock price, charts and financials

NASDAQ·Healthcare·Medical - Instruments & Supplies·USA

Latest market price

353.24

+3.08+0.88%

Overview Short InterestFilings

ISRGQT25Intuitive Surgical, Inc.·NASDAQ

Overview Short InterestFilings

353.24+0.88%

News

Up 0.9% — Intuitive Surgical, Inc. (ISRG) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript (seekingalpha.com).

Medium confidence

Loading chart...

Signal & projected range

Insider open-market saleHistorical pattern — not a prediction

Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)

Horizon

Unlock the projected rangeSee where this setup landed historically — with Premium.

Unlock with Premium

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Unlock with Premium to see the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands ofhistorical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →

BDX+0.39%$179.80 RMD-0.50%$219.95 MDLN-1.84%$34.05 WST-0.24%$336.94 SOLV-0.09%$90.03 BAX-1.89%$24.39 COO-6.22%$63.48 AVTR-2.43%$14.88

Snapshot

Index	S&P 500, NDX	P/E	40.19	EPS (ttm)	8.79	Insider Own	0.48%	Shs Outstand	353.28M	Perf Week	-4.34%

Market Cap	124.79B	Forward P/E	29.24	EPS next Y	12.08	Insider Trans	-1.10%	Shs Float	351.21M	Perf Month	-10.20%

Enterprise Value	119.16B	PEG	3.35	EPS next Q	2.61	Inst Own	86.89%	Short Float	2.01%	Perf Quarter	-17.20%

Income	3.14B	P/S	11.31	EPS this Y	22.86%	Inst Trans	0.00%	Short Ratio	2.28	Perf Half Y	-27.29%

Sales	11.03B	P/B	6.96	EPS next Y	11.87%	ROA	15.04%	Short Interest	7.07M	Perf YTD	-37.63%

Book/sh	50.79	P/C	21.03	EPS next 5Y	12.01%	ROE	17.84%	52W High	603.83 -41.50%	Perf Year	-24.84%

Cash/sh	16.80	P/FCF	40.20	EPS past 3/5Y	29.19% 21.77%	ROIC	15.11%	52W Low	328.56 7.51%	Perf 3Y	13.80%

Dividend Est.	-	EV/EBITDA	26.44	Sales past 3/5Y	17.39% 18.22%	Gross Margin	66.68%	Volatility	3.12% 2.75%	Perf 5Y	0.58%

Dividend TTM	-	EV/Sales	10.80	EPS Y/Y TTM	36.92%	Oper. Margin	31.28%	ATR (14)	11.66	Perf 10Y	362.42%

Dividend Ex-Date	-	Quick Ratio	3.91	Sales Y/Y TTM	32.11%	Profit Margin	28.45%	RSI (14)	37.42	Recom	2.39

Dividend Gr. 3/5Y	-	Current Ratio	4.96	EPS Q/Q	27.85%	SMA20	-6.34%	Beta	1.46	Target Price	491.15

Payout	0.00%	Debt/Eq	0.02	Sales Q/Q	18.52%	SMA50	-6.76%	Rel Volume	0.79	Prev Close	350.16

Employees	17,021	LT Debt/Eq	0.01	Earnings	Oct 20	SMA200	-23.50%	Avg Volume	3.00M	Price	353.24

IPO Date	Jun 16, 2000	Option/Short	Yes / Yes	EPS/Sales Surpr.	11.51% 2.37%	Net Debt/EBITDA	-0.61	Volume	2,358,870	Change	0.88%

Analyst Ratings

Date	Action	Analyst	Rating	Target
Aug-12-26	Upgrade	Oppenheimer	Perform → Outperform
Jul-30-26	Downgrade	HSBC	Buy → Hold	$391
Jul-28-26	Reiterated	UBS	Neutral	$570 → $500
Jul-27-26	Reiterated	Piper Sandler	Overweight	$470 → $357
Jul-17-26	Reiterated	Stifel Nicolaus	Buy	$670 → $550
Jul-17-26	Reiterated	Robert W. Baird		$525 → $500
Jul-17-26	Reiterated	Mizuho	Neutral	$500 → $400
Jul-17-26	Reiterated	Wells Fargo	Overweight	$466 → $487
Jul-17-26	Reiterated	Leerink Partners	Outperform	$454
Jul-17-26	Reiterated	Raymond James	Outperform	$603 → $483

Latest News· Times ET

Sep-09-26

Sep-09-2609:57AM

Intuitive Surgical, Inc. (ISRG) Presents at Wells Fargo 21st Annual Healthcare Conference Transcriptseekingalpha.com

06:30AM

Brokers Suggest Investing in Intuitive Surgical (ISRG): Read This Before Placing a Betzacks.com

05:56AM

ISRG Stock Trading at its Cheapest in 10 Years: Should You Buy Now?zacks.com

Sep-08-26

Sep-08-2602:51PM

Here's Why Intuitive Surgical, Inc. (ISRG) Fell More Than Broader Marketzacks.com

12:05PM

New meta-analysis shows statistically significant improvements in patient outcomes associated with da Vinci surgery versus laparoscopic and open surgery across 13 common benign conditionsglobenewswire.com

Sep-07-26

Sep-07-2607:56AM

ISRG's Ion Platform Is Quietly Becoming a Second Growth Enginezacks.com

01:16AM

Intuitive Surgical, Inc. $ISRG Shares Purchased by California State Teachers Retirement Systemdefenseworld.net

12:41AM

HB Wealth Management LLC Trims Stake in Intuitive Surgical, Inc. $ISRGdefenseworld.net

Sep-05-26

Sep-05-2611:15AM

Intuitive Surgical's Growth Has Cooled From Its Post-Pandemic Highs. Is That a Buying Opportunity or a Warning?fool.com

Sep-04-26

Sep-04-2606:45AM

Intuitive Surgical Vs. Stryker: Wall Street Loves Both But One Has a Quiet Advantage That Will Make Investors Money247wallst.com

06:30AM

2 Stocks Down 8% or More That Are Screaming Buys Right Nowfool.com

04:51AM

Are Robots the New Normal? Bet on these ETFs to Invest in the Futurezacks.com

Sep-03-26

Sep-03-2611:55PM

Intuitive Surgical, Inc. $ISRG Shares Bought by AXQ Capital LPdefenseworld.net

02:00PM

Is TMDX Stock Worth Buying as Growth Meets Rising Margin Pressure?Yahoo

07:10AM

3 Stocks Whose Competitive Walls Tower Over Nvidia'sfool.com

Company

Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both within the United States and across international markets. Its flagship offering, the da Vinci Surgical System, facilitates intricate operations through a minimally disruptive approach. Expanding beyond surgical applications, the company also provides the Ion endoluminal system, designed for diagnostic interventions like minimally invasive lung biopsies. Complementing its primary systems, Intuitive Surgical supplies a comprehensive array of instruments, including stapling tools, energy devices, and essential core components. Furthermore, it offers structured training programs to ensure proficient use of its technology, alongside extensive customer support services encompassing installation, repairs, and ongoing maintenance. The firm also integrates digital capabilities to deliver unified, connected solutions that optimize hospital performance through actionable insights. Established in 1995, Intuitive Surgical maintains its corporate headquarters in Sunnyvale, California.

Ownership

Total institutional ownership86.89%

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements

DataTimeframe

Line Item (USD, M)	TTM —	FY 2025 12/31/2025	FY 2024 12/31/2024	FY 2023 12/31/2023	FY 2022 12/31/2022	FY 2021 12/31/2021	FY 2020 12/31/2020	FY 2019 12/31/2019	FY 2018 12/31/2018
Total Revenue	11,034	10,065	8,352	—	—	—	—	—	—
Cost of Goods Sold Incl. D&A	3,677	3,422	2,718	—	—	—	—	—	—
Gross Profit	7,357	6,642	5,634	—	—	—	—	—	—
Selling, General and Administrative Excl. Other	2,491	2,385	2,140	—	—	—	—	—	—
Research and Development	1,415	1,312	1,145	—	—	—	—	—	—
Other Operating Expense	1	0	0	—	—	—	—	—	—
Operating Income	3,451	2,946	2,349	—	—	—	—	—	—
Interest Expense	0	0	0	—	—	—	—	—	—
Unusual Expense	—	—	—	—	—	—	—	—	—
Non-Operating Income (Expense)	355	366	325	—	—	—	—	—	—
Net Income Before Taxes	3,806	3,311	2,674	—	—	—	—	—	—
Income Taxes	647	435	336	—	—	—	—	—	—
Consolidated Net Income	3,139	2,856	2,323	—	—	—	—	—	—
Net Income From Continuing Operations	3,158	2,877	2,338	—	—	—	—	—	—
Net Income	3,139	2,856	2,323	—	—	—	—	—	—
EPS (Recurring)	8.85	8.00	6.54	—	—	—	—	—	—
EPS (Basic, Before Extraordinaries)	8.85	8.00	6.54	—	—	—	—	—	—
EPS (Diluted)	8.79	7.87	6.42	—	—	—	—	—	—
EBITDA	4,506	3,989	3,136	—	—	—	—	—	—
Other After Tax Adjustments	—	—	—	—	—	—	—	—	—
Stock Option Compensation Expense	—	—	—	—	—	—	—	—	—
Price To Earnings Ratio	40.19	71.96	81.30	—	—	—	—	—	—
Price To Sales Ratio	11.36	20.09	22.19	—	—	—	—	—	—
Gross Margin	66.68	65.99	67.46	—	—	—	—	—	—
Operating Margin	31.28	29.27	28.13	—	—	—	—	—	—
Net Margin	28.45	28.38	27.81	—	—	—	—	—	—
Shares Outstanding	355	357	355	—	—	—	—	—	—
Market Capitalization	125,400	202,191	185,296	—	—	—	—	—	—
Operating Lease Expense	—	—	—	—	—	—	—	—	—

Unlock full historical data

See years of past statements with Premium.

Unlock with Premium

Insider Trading Volume

Insider Trading

Insider	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Brosius Mark	EVP & Chief Mfg and Supply Cha	Sep 09 '26	Sale	350.20	23	8,055	812	Sep 09
Brosius Mark	EVP & Chief Mfg and Supply Cha	Sep 08 '26	Sale	361.23	46	16,617	835	Sep 09
Brosius Mark	EVP & Chief Mfg and Supply Cha	Aug 21 '26	Sale	375.57	77	28,919	881	Aug 21
Brosius Mark	EVP & Chief Mfg and Supply Cha	Aug 20 '26	Sale	396.37	77	30,520	958	Aug 21
Brosius Mark	EVP & Chief Mfg and Supply Cha	Aug 19 '26	Sale	394.26	77	30,358	1,035	Aug 19
Brosius Mark	EVP & Chief Mfg and Supply Cha	Aug 18 '26	Sale	394.00	77	30,338	1,112	Aug 19
Brosius Mark	EVP & Chief Mfg and Supply Cha	Aug 17 '26	Sale	390.67	77	30,082	1,189	Aug 19
GUTHART GARY S	Director	Aug 11 '26	Sale	400.00	10,000	4,000,000	1,245,679	Aug 12
Ladd Amy L	Director	Aug 11 '26	Sale	393.10	72	28,303	179	Aug 11
Ladd Amy L	Director	Aug 10 '26	Sale	379.00	400	151,600	251	Aug 11
LOEB GARY	EVP & Chief Legal and Complian	Aug 10 '26	Sale	379.00	400	151,600	5,320	Aug 10
Brosius Mark	EVP & Chief Mfg and Supply Cha	Jul 31 '26	Sale	351.00	28	9,828	1,266	Jul 31
Brosius Mark	EVP & Chief Mfg and Supply Cha	Jul 30 '26	Sale	346.83	28	9,711	1,294	Jul 31
Brosius Mark	EVP & Chief Mfg and Supply Cha	Jul 29 '26	Sale	360.21	28	10,086	1,322	Jul 29
Brosius Mark	EVP & Chief Mfg and Supply Cha	Jul 28 '26	Sale	365.58	28	10,236	1,350	Jul 29

open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR

QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.